-2,5-

Vladislav Deigin1, Natalia Linkova2, Olga Volpina1

  • 1The Laboratory of Synthetic Vaccines of Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Miklukho-Maklaya St., 16/10, Moscow 117997, Russia.

概括

开发口服可用的类药物是一项挑战. 使用分支皮佩拉-2,5-二的新平台创建了稳定的peptidomimetics与保存的生物活性,用于口服.